StockData
Vycor Medical Inc logo

Vycor Medical Inc (VYCO) stock

VYCOOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$0.07+0.00 (0.00%)

Close on Oct 19, 2026Market cap $2.24MP/E –Yield –

Vycor Medical operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Vycor Medical's operating income for the twelve months ending Jun 30, 2026 was $48.22K, up 113.8% year over year. For fiscal 2025 it was $33.90K. The highest annual figure on record is $40.19K in fiscal 2023.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$33.90K–
FY2024Dec 31, 2024-$9.15K-122.8%
FY2023Dec 31, 2023$40.19K–
FY2022Dec 31, 2022-$306.51K–
FY2021Dec 31, 2021-$435.95K–
FY2020Dec 31, 2020-$727.39K–
FY2019Dec 31, 2019-$601.39K–
FY2018Dec 31, 2018-$1.32M–
FY2017Dec 31, 2017-$1.31M–
FY2016Dec 31, 2016-$1.59M–
FY2015Dec 31, 2015-$1.99M–
FY2014Dec 31, 2014-$2.73M–
FY2013Dec 31, 2013-$2.28M–
FY2012Dec 31, 2012-$2.79M–
FY2011Dec 31, 2011-$4.63M–
FY2010Dec 31, 2010-$1.94M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$6.85K-86.6%
Q1 FY2026Mar 31, 2026$45.81K–
Q4 FY2025Dec 31, 2025-$36.53K-288.8%
Q3 FY2025Sep 30, 2025$32.09K–
Q2 FY2025Jun 30, 2025$51.15K+216.1%
Q1 FY2025Mar 31, 2025-$12.81K–
Q4 FY2024Dec 31, 2024$19.34K–
Q3 FY2024Sep 30, 2024-$35.14K–
Q2 FY2024Jun 30, 2024$16.18K-83.2%
Q1 FY2024Mar 31, 2024-$9.53K-128.7%
Q4 FY2023Dec 31, 2023-$64.06K–
Q3 FY2023Sep 30, 2023-$25.48K–
Q2 FY2023Jun 30, 2023$96.52K–
Q1 FY2023Mar 31, 2023$33.21K–
Q4 FY2022Dec 31, 2022-$91.20K–
Q3 FY2022Sep 30, 2022-$88.05K–
Q2 FY2022Jun 30, 2022-$74.37K-416.6%
Q1 FY2022Mar 31, 2022-$52.90K–
Q4 FY2021Dec 31, 2021-$164.20K–
Q3 FY2021Sep 30, 2021-$88.40K–
Q2 FY2021Jun 30, 2021$23.49K–
Q1 FY2021Mar 31, 2021-$206.85K–
Q4 FY2020Dec 31, 2020-$174.96K–
Q3 FY2020Sep 30, 2020-$206.37K–
Q2 FY2020Jun 30, 2020-$199.36K–
Q1 FY2020Mar 31, 2020-$146.68K–
Q4 FY2019Dec 31, 2019-$175.63K–
Q3 FY2019Sep 30, 2019-$165.67K–
Q2 FY2019Jun 30, 2019-$130.55K–
Q1 FY2019Mar 31, 2019-$162.84K–
Q4 FY2018Dec 31, 2018-$464.81K–
Q3 FY2018Sep 30, 2018-$132.72K–
Q2 FY2018Jun 30, 2018-$405.65K–
Q1 FY2018Mar 31, 2018-$314.55K–
Q4 FY2017Dec 31, 2017-$363.35K–
Q3 FY2017Sep 30, 2017-$295.61K–
Q2 FY2017Jun 30, 2017-$353.89K–
Q1 FY2017Mar 31, 2017-$299.72K–
Q4 FY2016Dec 31, 2016-$469.88K–
Q3 FY2016Sep 30, 2016-$315.22K–

More Vycor Medical figures

See a number that looks wrong?